Is Cannabis Helpful During Therapy Sessions for OCD?

PostedFebruary 27, 2026

UpdatedFebruary 27, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Obsessive-Compulsive Disorder (OCD) can make therapy sessions difficult due to anxiety and intrusive thoughts. Researchers are exploring cannabis and therapy sessions for OCD as a potential aid, with compounds like CBD helping reduce stress and support emotional regulation. Early studies on marijuana-assisted therapy for OCD suggest it may improve engagement during Exposure and Response Prevention (ERP) and enhance overall outcomes.

How Cannabis Can Support Therapy

Introducing cannabis in therapy requires careful monitoring, dosing, and professional guidance. When used appropriately, it may offer valuable treatment support with cannabis and enhance the overall therapeutic use in clinical settings.

Reduced Anxiety

Cannabis may help lower stress and fear responses, allowing patients to face ERP exercises with more confidence.

Improved Focus

By calming intrusive thoughts, cannabis can enable better concentration and participation in therapy.

Enhanced Outcomes

Patients may experience more consistent progress when cannabis is incorporated thoughtfully into sessions.

In summary, cannabis may be a valuable addition to therapy for some individuals with OCD. Always consult a healthcare professional to ensure safe and effective use.

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.